Status:
COMPLETED
Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19
Lead Sponsor:
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Conditions:
COVID
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
As the world faces COVID-19, the search for effective treatments against the disease and its complications has turned its gaze to drugs that are classically used in other infectious diseases. Some dru...
Detailed Description
The aim of the study is to assess the efficacy of Ivermectin-Azithromycin-Cholecalciferol combination in COVID-19 in early stages of the disease with outpatient management. Enrollment of subject into...
Eligibility Criteria
Inclusion
- Confirmed infection of SARS-CoV2 virus
- Mild COVID-19
- Symptoms of respiratory illness
- Cough
- Fever (T \>38 °C)
Exclusion
- Allergy to any of the drugs treatment
Key Trial Info
Start Date :
March 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04399746
Start Date
March 15 2020
End Date
June 10 2020
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Outpatient treatment
Mexico City, Mexico, 14050